Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿µ¾ç½ÇÁ¶ »óÅÂÀÎ Áö¼Ó¼º ¿Ü·¡º¹¸·Åõ¼® ȯÀÚ¿¡¼­ ´Ü¹éµ¿È­È£¸£¸óÀÌ Ã¼Á¶¼º ¹× ´Ü¹éÁú ´ë»ç¿¡ ¹ÌÄ¡´Â ¿µÇâ The Effect of Anabolic Steroid on Body Composition and Protein Metabolism in Malnourished CAPD Patients

´ëÇѽÅÀåÇÐȸÁö 1997³â 16±Ç 4È£ p.724 ~ 729
¼Ò¼Ó »ó¼¼Á¤º¸
À̽¿ì/Seoung Woo Lee ±Ç°ÇÈ£/±è°æ¾Æ/½ÅÇöÁÖ/¹è¼º±Ç/¼Û±â»ê/±è¹®Àç/¿À¹ÎÈ­/±èÁøÁÖ/Kun Ho Kwon/Gyeong A Kim/Hyun Joo Shin/Sung Kwon Bae/Ki San Song/Moon Jae Kim/Min Wha Oh/Jin Ju Kim

Abstract

¿ä¾à
Áö¼Ó¼º ¿Ü·¡ º¹¸·Åõ¼®(CAPD) ȯÀÚ¿¡¼­ ´Ü¹éÁú-¿¡³ÊÁö ¿µ¾â½ÇÁ¶°¡ 18-56%·Î ºó¹øÈ÷ °ü
ÂûµÇ¸ç ÀÌ´Â À¯º´À² ¹× »ç¸Á·üÀÇ Áõ°¡¿Í ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ¾î ¿µ¾ç½ÇÁ¶¸¦ ±³Á¤Çϱâ À§ÇÑ ½Ã
µµ·Î ´Ü¹éµ¿È­ È£¸£¸óÀÇ Åõ¿©°¡ Á¦½ÃµÇ°í ÀÖ´Ù. ´Ü¹éµ¿È­ È£¸£¸ó Áß anabolic steroid(AS)´Â
¸»±â½ÅºÎÀüÁõ ȯÀÚ¿¡¼­ ºóÇ÷Ä¡·áÁ¦·Î ÀÌ¿ëµÇ¾î ¿ÔÀ¸¸ç nitrogen-retaining capacity°¡ °­ÇÑ
´Ü¹éµ¿È­ ÀÛ¿ëÀÌ ÀÖ´Ù. ÀúÀÚ µîÀº CAPDȯÀÚ¿¡¼­ AS°¡ üÁ¶¼º ¹× ´Ü¹éÁú ´ë»ç¿¡ ¹ÌÄ¡´Â
È¿°ú¸¦ ¾Ë¾Æº¸°íÀÚ ¿µ¾ç½ÇÁ¶ »óÅÂÀÎ 7¿¹ÀÇ CAPDȯÀÚ¿¡¼­ ASÀÎ nandrolone decanoate(ND)
¸¦ ¸Å´Þ 200mg¾¿ 5°³¿ù µ¿¾È ±ÙÁÖÇÏ¿© Åõ¿©ÀüÈÄÀÇ Ã¼Á¶¼º, Ç÷û »ýÈ­ÇÐÁöÇ¥, ±×¸®°í Ç÷Àå
¹× Åõ¼®¾×³» ¾Æ¹Ì³ë»êÀ» ÃøÁ¤ÇÏ¿© ´ÙÀ½ÀÇ °á°ú¸¦ ¾ò¾ú´Ù.
1) ´ë»óȯÀÚ 7¿¹ÀÇ Æò±Õ ¿¬·ÉÀº 53.6¡¾11.5¼¼, ³²³àºñ´Â ³²ÀÚ 2¿¹, ¿©ÀÚ 5¿¹, CAPD±â°£Àº
28.5¡¾18.7°³¿ùÀ̾ú°í ´ç´¢º´ ȯÀÚ°¡ 2¿¹ ÀÖ¾ú´Ù
2) ND Åõ¿©°Ç ÈÄ % lean body mass(52.6¡¾11.7 vs. 57.3¡¾11.3 %)°¡ Áõ°¡ÇÏ´Â °æÇâÀ» º¸
¿´´Ù.
3) »ýÈ­ÇÐÀû °Ë»ç»ó IGF-I(172.4¡¾88.5 vs. 204.1¡¾85.8ng/ml, p<0.05)¿Í transferrin (213.6
¡¾55.4 vs. 239.0¡¾55.3mg/dl, p<0.05)Àº ¸ðµÎ Åõ¿© ÈÄ ÀÇÀÇ ÀÖ°Ô Áõ°¡ÇÏ¿´°í Ç÷û
prealbumin, ¾ËºÎ¹Î, Å©·¹¾ÆƼ´ÑÀº Áõ°¡ÇÏ´Â °æÇâÀ» º¸¿´À¸¸ç, total CO2(31.1
¡¾4.5 vs. 25.¡¾2.5mM/L, p<0.05)´Â ÀÇÀÇ ÀÖ°Ô °¨¼ÒÇÏ¿´°í urea nitrogen appearance´Â °¨¼Ò
ÇÏ´Â °æÇâÀ» º¸¿´´Ù.
4) Çʼö¾Æ¹Ì³ë»êÀº Ç÷Àå³óµµ(738.3¡¾206.5 vs. 492.5¡¾187.2¥ìmol/L, p<0.05) ¹× Åõ¼®¾×À¸·Î
ÀÇ ¹è¼³·®(565.0¡¾186.1 vs. 377.4¡¾113.9¥ìmol/L, p<0.05)ÀÌ Åõ¿©Àüº¸´Ù Åõ¿© ÈÄ ¸ðµÎ ÀÇÀÇ
ÀÖ°Ô °¨¼ÒÇÏ¿´À¸¸ç, ÃÑ ¾Æ¹Ì³ë»ê ¹× ºñÇʼö¾Æ¹Ì³ë»êÀº Ç÷Àå³óµµ°¡ Åõ¿© ÈÄ Áõ°¡ÇÏ°í Åõ¼®¾×
À¸·ÎÀÇ ¼Ò½Ç·®Àº Åõ¿© ÈÄ °¨¼ÒÇÏ´Â °æÇâÀ» º¸¿´´Ù.
ÀÌ»óÀÇ °á°ú·Î ¿µ¾ç½ÇÁ¶»óÅÂÀÎ CAPDȯÀÚ¿¡¼­ ´Ü¹éµ¿È­È£¸£¸óÀÎ ASÀÇ Åõ¿© ÈÄ ºñ·Ï ü
Á¶¼ºÀÇ ÀÇÀÇ ÀÖ´Â º¯È­´Â ¾ø¾úÀ¸³ª ¿µ¾ç»óÅ ÁöÇ¥°¡ È£ÀüµÇ°í ¾Æ¹Ì³ë»ê ƯÈ÷ Çʼö¾Æ¹Ì³ë»ê
ÀÇ ¹è¼³ÀÌ °¨¼ÒÇÑ °ÍÀ¸·Î º¸¾Æ ±ÙÀ°¿¡¼­ Çʼö¾Æ¹Ì³ë»êÀ» ÀÌ¿ëÇÑ ´Ü¹éÁúÇÕ¼ºÀÌ Áõ°¡ÇÑ °ÍÀ¸·Î »ç·áµÈ´Ù.
#ÃÊ·Ï#
To evaluate the effect of anabolic steroid(AS) on body composition and protein
metabolism in malnourished CAPD patients, 7 CAPD patients who were proved to be
malnourished by subjective global assessment received 200mg of AS, nandrolone
decanoate, by intramuscular route monthly for 5 months. We analyzed the body
composition, biochemical nutritional markers, plasma and dialysate amino acids(AA)
before and after administration of AS. The mean was 53.6¡¾11.5 yearn, the serf ratio
was 2:5, and the duration of CAPD was 28.5¡¾18.7 months. Two patients were diabetics.
Five months after AS administration, %lean body mass seemed to increase from 52.6¡¾
11.7 to 57.3¡¾11.0% (p>0.05), but there were no significant changes in body weight and
body mass index. Serum insulin-like growth factor-I(172.4¡¾88.5 vs.204.1¡¾85.8ng/m1,
p<0.05) and transferrin(213.6¡¾55.4 vs. 239.0¡¾55.33mg/dl, p<0.05) were significantly
increased, and serum total CO2(31.1¡¾4.5 vs. 25.9¡¾2.5mM/L, p<0.05) were
significantly decreased. Urea nitrogen appearance(4.0¡¾2.0 vs. 3.6¡¾1.6g/day) seemed to
be decreased. Both plasma essential AA(EAA) level(738.3¡¾206.5 vs. 492.5¡¾187.2¥ì
mol/L, p<0.05) and peritoneal EAA loss(565.0¡¾186.1 vs. 377.4¡¾113.9¥ì mol/day, p<0.05)
decreased significantly after administration. Plasma total and non-essential amino
acids(NEAA) level tended to be increased and peritoneal total and NEAA loss seemed to
be decreased without statistical significance. In conclusion, AS seems to have anabolic
effect and be useful in the correction of malnutrition in CAPD patients.

Å°¿öµå

CAPD; Nutrition; Amino acids; Anabolic steroid;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS